Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Uniphar PLC ( (GB:UPR) ) has issued an update.
Uniphar plc has published its 2025 annual report and the notice of its 2026 Annual General Meeting, which will take place on 7 May 2026 at the offices of William Fry LLP in Dublin. The documents, including the form of proxy, are available on the company’s website and can be inspected at Uniphar’s registered office during normal business hours until the AGM.
The company is encouraging shareholder engagement through in-person attendance, advance proxy voting and the submission of written questions ahead of the meeting by post or electronic means. A listen-only conference call will be provided for shareholders unable to attend, though voting and questions must be submitted in advance, underscoring Uniphar’s focus on broad but orderly investor participation in its governance processes.
More about Uniphar PLC
Uniphar plc is a Dublin-headquartered diversified healthcare services group operating across Europe, North America, APAC and MENA. Through its Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail divisions, it services more than 200 multinational pharmaceutical and medical technology manufacturers, distributing pharmaco-medical products to over 160 countries.
The group is Ireland’s leading pharmaceutical wholesaler with a growing network of symbol group retail pharmacies and a portfolio of own-brand, in-licensed and consumer products. It also acts as a pan-European medical device distributor and solutions partner, and runs a global pharma services business that supports companies in bringing innovative and hard-to-access medicines to market.
For a thorough assessment of UPR stock, go to TipRanks’ Stock Analysis page.